Fujifilm

For profit

Also known as: Cellular Dynamics International, Inc. - A FUJIFILM Company | Fuji Film | Fujifilm Pharmaceuticals U.S.A., Inc. | Japan Regenerative Medicine Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2014

Last known activity

Jun 1, 2022

Timeline

1930s

Jan 1, 1934
Fujifilm— Founded

2000s

Jan 1, 2008
Taisho Toyama Pharmaceutical Ltd.— Acquired

Drugs by trial phase (34 distinct, 65 trials)

Phase 3 (1 own, 11 via acquisition)

Phase 2 (6 own, 5 via acquisition)

Phase 1 (2 own, 8 via acquisition)

Other trials (1 own, 0 via acquisition)

whole blood

Indications

Studied for

Subsidiaries (1 direct, 3 total across the full acquisition tree)

Recent trials (13)

NCT05318573Lead sponsorPhase 2Jun 1, 2022
NCT04358549Lead sponsorPhase 2Apr 17, 2020
NCT04047251Lead sponsorPhase 1Sep 19, 2019
NCT03486353Lead sponsorPhase 2Oct 1, 2018
NCT03440450Lead sponsorPhase 1Mar 22, 2018
NCT03194685Lead sponsorPhase 1/Phase 2May 5, 2017
NCT03194685Study directorPhase 1/Phase 2May 5, 2017
NCT03434808CollaboratorN/AJan 13, 2017
NCT03434808Overall official - principal investigatorN/AJan 13, 2017
NCT02781922Lead sponsorPhase 3Jun 1, 2016
NCT02454010Lead sponsorPhase 1Jan 1, 2016
NCT02661542Lead sponsorPhase 1/Phase 2Jan 1, 2016
NCT02193958Lead sponsorPhase 1/Phase 2Jul 1, 2014

Details

Founded: Tokyo, JP Jan 1, 1934
Last known activity: Jun 1, 2022